LANGLARA

Serial Number 98285721
730

Registration Progress

Application Filed
Nov 27, 2023
Under Examination
Oct 1, 2024
Approved for Publication
Aug 6, 2024
Published for Opposition
Aug 6, 2024
Registered

Attorney Assistance

Statement of Use Due - Extension 1 Granted
Due: Oct 01, 2025 76 days

Trademark Image

LANGLARA

Basic Information

Serial Number
98285721
Filing Date
November 27, 2023
Published for Opposition
August 6, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
730
Status Date
Mar 19, 2025
Application
Pending
Classes
005

Rights Holder

Lannett Company, Inc.

03
Address
Suite 155
1150 Northbrook Drive
Trevose, PA 19053

Ownership History

Lannett Company, Inc.

Original Applicant
03
Trevose, PA

Sunshine Lake Pharma Co., Ltd.

Original Applicant
03
Guangdong Province CN

Lannett Company, Inc.

Owner at Publication
03
Trevose, PA

Sunshine Lake Pharma Co., Ltd.

Owner at Publication
03
Guangdong Province CN

Legal Representation

Attorney
Tristram R. Fall, III, Esquire

USPTO Deadlines

Next Deadline
76 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
October 01, 2025
Extension Available
Until October 01, 2025

Application History

12 events
Date Code Type Description Documents
Mar 20, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 19, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Mar 19, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Mar 19, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 1, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 6, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 6, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 17, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 27, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 26, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 17, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 30, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Antidiabetic pharmaceutical preparations; Pharmaceutical preparations for the treatment of diabetes

Classification

International Classes
005